La Jolla Pharma Company Profile
What is the competitive landscape for LA JOLLA PHARMA
LA JOLLA PHARMA has one approved drug.
There are eleven US patents protecting LA JOLLA PHARMA drugs.
Summary for La Jolla Pharma
| US Patents: | 11 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for La Jolla Pharma: | See patent lawsuits for La Jolla Pharma |
Drugs and US Patents for La Jolla Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-002 | Dec 21, 2017 | DISCN | Yes | No | 11,096,983 | ⤷ Start Trial | ⤷ Start Trial | ||||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-003 | Dec 23, 2021 | RX | Yes | Yes | 10,335,451 | ⤷ Start Trial | ⤷ Start Trial | ||||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-003 | Dec 23, 2021 | RX | Yes | Yes | 10,500,247 | ⤷ Start Trial | ⤷ Start Trial | ||||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-001 | Dec 21, 2017 | AP | RX | Yes | Yes | 10,548,943 | ⤷ Start Trial | ⤷ Start Trial | |||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-002 | Dec 21, 2017 | DISCN | Yes | No | 9,220,745 | ⤷ Start Trial | ⤷ Start Trial | ||||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-003 | Dec 23, 2021 | RX | Yes | Yes | 9,220,745 | ⤷ Start Trial | ⤷ Start Trial | ||||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-003 | Dec 23, 2021 | RX | Yes | Yes | 9,572,856 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for La Jolla Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 106061493 | ⤷ Start Trial |
| Mexico | 2016008108 | ⤷ Start Trial |
| European Patent Office | 3607962 | ⤷ Start Trial |
| China | 119700926 | ⤷ Start Trial |
| China | 112546197 | ⤷ Start Trial |
| Taiwan | 201733610 | ⤷ Start Trial |
| Japan | 2025114753 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
